Skip to main content

Advertisement

  • Correction
  • Open Access

Correction to: Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial

  • 1, 13Email author,
  • 2, 3,
  • 4,
  • 5,
  • 6,
  • 7,
  • 8,
  • 9,
  • 10,
  • 11,
  • 12 and
The Journal of Headache and PainOfficial Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache"201920:1

https://doi.org/10.1186/s10194-018-0948-x

  • Received: 14 November 2018
  • Accepted: 14 November 2018
  • Published:

The original article was published in The Journal of Headache and Pain 2018 19:98

Correction to: J Headache Pain (2018) 19:98

https://doi.org/10.1186/s10194-018-0928-1

Following publication of the original article [1], the authors notified us that a part of the Figure 3 legend was omitted during the proofing stage.

The original publication has been corrected. The incorrect and correct figure legends are presented below.

• Originally published legend for Figure 3:

≥1-Point Reduction in Pain Intensity at 30, 60, and 120 Minutes for (a) First Attack and (b) All Attacks

• Corrected Figure 3 legend:

≥1-Point Reduction in Pain Intensity at 30, 60, and 120 Minutes for (a) First Attack and (b) All Attacks. Models are adjusted for the patients’ baseline pain score, use of preventive therapies, and presence of aura; data for number of patients are unadjusted numbers. Abbreviation: nVNS, non-invasive vagus nerve stimulation

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Neuroalgology Unit, Carlo Besta Neurological Institute and Foundation, Milan, Italy
(2)
Headache Science Centre, IRCCS C. Mondino Foundation, Pavia, Italy
(3)
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
(4)
Neurophysiology and Pain Unit, University of Bari Aldo Moro, Bari, Italy
(5)
IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
(6)
Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy
(7)
Department of Neuroscience, University of Turin, Turin, Italy
(8)
Headache Centre, University Hospital of Careggi, Florence, Italy
(9)
IRCCS Neuromed, Pozzilli (IS), Italy
(10)
Neurologic Clinic, Santa Maria della Misericordia Hospital, Perugia, Italy
(11)
electroCore, Inc, Basking Ridge, NJ, USA
(12)
Headache and Pain Unit, IRCCS San Raffaele Pisana, Rome, Italy
(13)
Department of Fondazione IRCCS Istituto Neurologico C. Besta, U.O. Neurologia III – Cefalee e Neuroalgologia, Via Celoria 11, 20133 Milan, Italy

Reference

  1. Grazzi et al (2018) Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial. J Headache Pain 19:98. https://doi.org/10.1186/s10194-018-0928-1 View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2019

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement